• Lexaria’s DehydraTECH(TM) drug delivery platform a feasible and healthier alternative to other delivery methods
• The fast-acting, high absorption technology improves dipping experience and consumer satisfaction
• Company expects to more than double its 2019 revenue this year, will pursue a new capital markets strategy to qualify for listing on a nationally recognized U.S. exchange

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms and one of the few companies active in the field of cannabis to have developed formal relationships with Fortune 500 industry leaders, is experiencing strong demand from many companies requesting pre-processed DehydraTECH(TM)-enhanced bulk powders.

The company’s revolutionary drug delivery platform DehydraTECH(TM) accelerates human intestinal cell absorption of bioactive substances administered without the need for inhalational dosing, co-administration with sugars or sweeteners, and other unhealthy practices. It is applicable to a wide variety of bioactive substances, including cannabis and nicotine. Utilization of the DehydraTECH(TM) drug delivery platform increases the absorption levels of CBD in human intestinal cells by 499%. As much as 1,937% more CBD is delivered into animal brain tissue after 8 hours using the enhanced technology in comparison with generic industry MCT coconut-oil formulations, according to recent studies.

Vaping and smoking have been shown to be dangerous methods of delivering drugs. Lexaria developed its technology as a safe and fast delivery method of bioactive substances via oral ingestion by bypassing potentially unhealthy practices such as inhalation. Proven to deliver up to 10 times more active ingredients in comparison to traditional edible, DehydraTECH(TM) is the first platform of its kind that allows users to access the primary benefits of inhalation – speed and efficiency – while circumventing the risks of inhalation.

The company currently has 16 patents granted and more than 60 patent applications worldwide. It is the only company to hold a patent for improved delivery of nicotine and all non-psychoactive and psychoactive cannabinoids, including tetrahydrocannabinol. The platform reduces the time of onset of THC by four times on average (http://ibn.fm/AvVxl).

Lexaria also obtained two patents for treating certain conditions including, but not limited to heart disease, neurological diseases such as Alzheimer’s, Parkinson’s, schizophrenia, and others. The platform has potential applications to assist treatment of the common form of dementia as well as other nervous system diseases.

In 2019, the company finalized a new contractual relationship with a GMP-certified, FDA registered production company to get enhanced DehydraTECH(TM) powders to market in the U.S. with current capacity of roughly 200,000 servings per day (http://ibn.fm/T0TMV).

The versatility and multiple potential applications of the DehydraTECH(TM) drug delivery platform, paired with the proven benefits it offers over other delivery methods, are some of the key factors driving demand and revenue growth for Lexaria Bioscience in 2020. The company expects to more than double its 2019 revenue this year from both existing clients and by leveraging a rich pipeline of prospective additional clients.

The company has already taken steps to increase the reach of its technology via a recent agreement with Cannadips Cannabis (http://ibn.fm/OUJa6). Under the definite agreement, Cannadips will use Lexaria’s technology to enhance its products available in California and nationwide. More specifically, DehydraTECH(TM) will be able to reduce throat irritation normally associated with some terpenes, which are part of the base ingredients of Cannadips THC. The 10-year licensing agreement is expected to considerably improve dipping experience and consumer satisfaction.

The expected revenue increase will support Lexaria’s future growth plans and its new capital markets strategy to qualify for listing on a nationally recognized U.S. exchange. This move is anticipated to significantly increase the company’s market visibility and expand its customer base.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• SRAX’s proprietary platform allows consumers to own, monetize their data
• While CCPA is now law, consumers aren’t feeling protected
• Big marketers looking for correct, effective data; BIGtoken delivers

SRAX Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, has developed a consumer-managed data marketplace that delivers a digital competitive advantage for brands. Through its exclusive platform BIGtoken, SRAX provides everyone in the Internet ecosystem choice with transparency and compensation. Consumers who use BIGtoken are able to own and monetize their data while brands that purchase access to that data benefit from higher ROIs.

Consumers are increasingly demanding to keep their data private. In addition to simply desiring privacy, this movement also stems from a growing awareness of the value of that data. The California Consumer Privacy Act (CCPA) was created in response to the public’s demands. The law took effect on January 1, 2020, and created new consumer rights relating to access, deletion and sharing of personal information collected by businesses. Consumers are concerned that smart devices in their homes are being used to track excessive information and that advertisers have access to that data.

“The goal of the CCPA was to reign in the power that companies like Facebook have over consumers,” SRAX COO Kristoffer Nelson stated in a news release (http://ibn.fm/QbItB). Ironically, Google and Facebook might actually be exempt from the CCPA. Nelson went on to explain that the law was written by well-meaning people who simply did not have a full understanding of the technology, data or advertising.

“The law that was created to challenge big-tech surveillance further entrenches these legacy incumbents while harming small businesses and publishers,” Nelson continued. “But the law is now in effect, and the industry must comply.” The good news is that the law will create a better Internet experience for the consumer by forcing a more transparent and balanced relationship between the consumer and the company.

While the new CCPA regulation has left some tech companies scrambling, SRAX is ahead of the game on this new industry standard. From the outset, the Company believed strongly in putting power in the hands of the consumer – BIGtoken was created on that principle. BIGtoken is seeing three to five thousand new users join daily, a result indicative of today’s consumer’s appreciation for the platform’s open, honest data handling.

Currently, 16.5 million users worldwide have signed into the BIGtoken app, which is available for download in the App and Google Play stores. Through this app, consumers control their own data, deciding for themselves what is and isn’t shared. The consumer manages what companies can buy their data and how that data is used. In turn, this control benefits companies because they are only receiving verified consumer data, allowing them to better reach and serve audiences.

Big marketers aren’t interested in buying bad data anymore. They want information from consumers who are interested in their products, which is exactly the kind of information that SRAX is empowering consumers to take control of.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Lexaria’s fast-acting, high absorption technology will improve dipping experience and consumer satisfaction
• Partnership will enable Lexaria’s to provide its DehydraTECH(TM) drug delivery platform to Cannadips Cannnabis products in California and nationwide
• Cannadips to open one-of-a-kind cannabis oral pouch and dip research facility

Global innovators in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) will provide its patented DehydraTECH(TM) technology to Cannadips Cannabis for use on the latter’s market in California and nationwide according to a new definitive agreement. Currently, Cannadips Cannabis Tins are sold in California. Each tin contains 15 pouches with 10 mg of tetrahydrocannabinol each, no nicotine, no tobacco, and all-natural sweeteners. The company also has a high-dose version with 15 pouches and 20 mg of cannabis-derived THC each (http://ibn.fm/N0pdA).

Lexaria’s DehydraTECH(TM) drug delivery platform is perfectly suited to improve the dipping experience through its effective, high absorption technology. Cannadips uses multi spectrum oils as base ingredients. The oils are rich in high-quality terpenes, which ensure the much-coveted entourage effect. DehydraTECH(TM) minimizes the throat irritation usually associated with some terpenes.

“Lexaria is building a stronger relationship with the Cannadips brand and applying DehydraTECH to Cannadips cannabis represents our latest advance,” Chris Bunka, CEO of Lexaria Bioscience Corp., stated in a news release. “Our DehydraTECH technology empowers a scalable supply chain across state lines for our cannabis brand licensees. We are excited that Cannadips is interested in activating the Lexaria technology in additional key state markets.”

The licensing agreement provided by Lexaria grants Cannadips exclusive rights for this product format for the U.S. market for 10 years, with the option to expand the license to Canada, Mexico and/or Europe.

According to Case Mandel, co-founder and chief executive officer of Cannadips Cannabis, the agreement will allow Cannadips to partner with operators in other states and bring its cannabis technology across state lines. “Our cannabis oral pouch and dip research facility in Humboldt is going to be the first of its kind in our brand new 4,000 square foot facility. We are also highly interested in activating the Canadian Oral Pouch Cannabinoid market,” Mandel added. Cannadips’ new 4,000 square foot oral cannabinoid research and development facility in Arcata, California will house manufacturing, corporate offices, distribution, and retail.

Lexaria Bioscience has launched a revolutionary technology that accelerates intestinal absorption of bioactive substances administered without the need for inhalational dosing, co-administration with sweeteners or sugars, and other unhealthy practices. It is applicable to absorption of cannabis and nicotine, among other bioactive substances (http://ibn.fm/GdBAc). The DehydraTECH(TM) drug delivery platform is patented for all non-psychoactive cannabinoids as well as for tetrahydrocannabinol and psychoactive cannabinoids. The platform reduces the time of onset of THC by four times on average (http://ibn.fm/DHOzB).

Lexaria is the leading company in the world that holds patents for oral delivery of all cannabinoids. The company holds 60 globally pending patents. Recently, Lexaria obtained two patents for treating certain conditions including, but not limited to, heart disease, neurological diseases such as Alzheimer’s, Parkinson’s, schizophrenia and others. The technology has potential applications to assist treatment of the common form of dementia as well as other nervous system diseases.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Sigma Labs highlighted in Barron’s as the ‘quality control of the 3-D printing world’.
• 3D printing demand fueled by increasing industry adoption, rising investments.
• 35% annual growth forecast for the foreseeable future.
• SGLB’s PrintRite3D(R) software eliminates quality-assurance barriers to 3D-metal-printing growth; only product of its kind enabling in-process quality control.

Sigma Labs Inc. (NASDAQ: SGLB), a leading developer of quality-assurance software for the commercial 3D-printing industry, is steadily strengthening its position in the burgeoning additive marketing (AM), or 3D metal printing, space. While forecast numbers vary, a recent “Barron’s” article quotes an industry expert predicting consistent 35% annual growth in the specialized market for the foreseeable future (http://ibn.fm/4FS6K). That growth, said the article, comes as 3D metal printing technology partnered with artificial intelligence offers significant benefits in a wide range of verticals. With its unmatched quality control technology, SGLB appears positioned at the vanguard of an industry poised for explosive growth.

As the applicability of 3D metal printing continues to be realized across an increasingly varied list of industries—from healthcare to aerospace to high-end automotive manufacturing—analysts are struggling to pin down even an approximate estimate for the market’s potential size. Whether it be a question of millions of dollars—or billions—experts are preparing for the next stage in the nascent industry’s evolution (http://ibn.fm/BtRrA).

“We have a market [of] $1 or $2 billion in parts today,” said Claus Emmelmann, head of Germany’s Fraunhofer Institute, a leading institute for development of industrial solutions in additive marketing. That figure only accounts for less than 1% of Emmelmann’s definition for the overall market of metal parts—and Emmelmann believes the market will grow about 35% a year for “a long time,” with 3-D metal printing potentially becoming a $50 billion business by the end of the decade.

While the benefits of 3D metal printing are significant, technological barriers have impeded industrial adoption. “One of the most important problems is qualifying the production of parts,” said Emmelmann, who stressed that the process for designing and qualifying satisfactory parts is expensive and time consuming.

Scaling volume for 3D metal part production has been hampered by this process, leaving industry players seeking a solution. For 3D metal printing to achieve mass adoption, the challenges of low-quality yields and high post-production inspection costs must be resolved. The 3D metal manufacturing quality assurance problem requires a fix that increases yields and deeply cuts post-process inspection costs.

“That’s where . . . Sigma comes in,” the “Barron’s article states. “The small New Mexico-based company sells products to improve quality and validate parts. They are the quality control of the 3-D printing world.”

Sigma has earned this title by creating its exclusive PrintRite3D(R) software, which uniquely provides nondestructive quality assurance during the 3D printing of metal parts. PrintRite3D is the only known additive manufacturing solution that enables in-process quality control of 3D metal printing, allowing errors to be detected and corrected in real time—saving a significant amount of time and money. Due to its reputation and unique ability to remove obstacles impeding the burgeoning industry’s accelerated growth, SGLB has developed a technology that  appears to be essential to enabling the3D metal parts  industry’s rapid growth.

By providing the quality-assurance solution that the 3D metal printing industry needs to transform mainstream manufacturing, SGLB intends to capitalize on the growth in 3D printing across a wide variety of sectors, especially those requiring exacting specifications like aerospace, automotive and biomedical.

Additionally, Emmelmann isn’t the only one with a rosy outlook on the future of 3D metal printing. According to a report by Grand View Research Inc., the global 3D metal printing market size is expected to reach $3.05 billion by 2025, progressing at a CAGR of 31.8% during the forecast period (http://ibn.fm/aLahT).

The Grand View report noted that “increasing adoption of 3D printing as a mainstream manufacturing method and rising investments in research & development (R&D) of 3D metal printing are anticipated to fuel product demand.” The report also observed that “use of 3D metal printing is prominent in the aerospace and defense industry owing to rapid prototyping and manufacturing speed offered by 3D printing.”

To date, Sigma Labs has engaged 19 beta customers with some of the biggest names in the industry, and two of the programs have already awarded Phase 2 contracts for SGLB’s RTE program. SGLB’s advanced computer-aided software, PrintRite3D, revolutionizes the quality control issues for commercial additive manufacturing, and for the first time enables nondestructive quality assurance mid-production–uniquely allowing errors to be corrected in real time. Sigma Labs is delivering key software to unlock the full potential of 3D metal printing and will likely reap the benefits of the sector’s incredible growth.

For more information about Sigma Labs, please visit www.sigmalabsinc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• The deal with Roger Bloss and his company will help expand the reach of InsuraGuest’s insurance platform
• InsuraGuest’s platform can integrate with 71 hotel and vacation rental property management systems, giving it access to millions of rooms worldwide
• Vacation rental revenue stood at $57,669 billion in 2019 with a market growth rate of 6.9%

InsuraGuest Inc., developers of a proprietary InsurTech platform to deliver insurance products to the hotel and vacation rental market, has signed an international sales contract with world-famous hotelier Roger Bloss and his company Cal-Vegas, Inc. The contract with InsuraGuest will help Bloss leverage his vast network and experience to boost hotel sales and onboarding of InsuraGuest’s platform around the world.

“InsuraGuest is unlike any other InsurTech product on the market, and Roger Bloss is unlike any hotelier,” Douglas Anderson, chairman and CEO of InsuraGuest stated in a news release (http://ibn.fm/1MSfd). “We are proud and honored to work with someone of Roger’s caliber to provide the benefits of InsuraGuest to many more hotels around the world.”

Bloss has over four decades of experience in the hospitality industry. He founded Vantage Hospitality Group in 1996 and has held executive positions with several major hotel franchise companies. Cal-Vegas was formed to own and manage lodging facilities throughout the U.S. on behalf of third-party owners as well as for its own account.

The contract will allow InsuraGuest to further expand its international reach. The company has already gained a firm foothold on the rapidly growing vacation rental market with its proprietary software platform offering specialized insurance coverage to all guests from check-in to check-out (http://ibn.fm/Zqb17).

Vacation rental revenue was $57.669 billion with a market growth rate of approx. 7% in 2019. U.S. travel to overseas markets totaled 35.1 million, up by 7%. About 25 percent of Americans report engaging with short-term rental platforms (23 percent), up 277 percent. The vacation rental market is projected to reach $63 billion by 2024, advancing at an annual growth rate of 5.51 percent in 2020.

InsuraGuest entered the vacation rental sector at the end of September 2019 by signing a software integration deal with San Francisco-based Hostfully, Inc., rated as one of the best property management systems in the world. InsuraGuest’s InsurTech platform can integrate with around 71 different property management systems, giving it access to millions of rooms worldwide.

The company’s proprietary software platform delivers a specialized guest protection policy to the hotel or vacation rental property to protect the guest during their stay while on the property. Hotels and vacation rental properties purchase an InsuraGuest Guest Protection Policy, which is automatically extended to each of their guests, including their room occupants, at the time of check-in; similar to a resort or amenity fee. The specialized policy covers accidental in-room damage, theft and damage of personal property, as well as accidental medical expenses and accidental death and dismemberment.

The policy was created to fill a gap left by traditional traveler’s insurance, which doesn’t cover a number of things that can happen inside hotels or vacation rental properties, putting both the guest and the hotel or property owner at risk. InsuraGuest Guest Protection Policy is complimentary to homeowners and/or general liability insurance coverage, serving as the first line of defense for the guest and the property.

InsuraGuest is working to expand the scope of its insurance products to cover European Union member states and the United Kingdom, as well as Asia before mid-2020. Europe’s hospitality stay market is more than double the market size in the United States, which means the InsuraGuest insurance platform has even greater potential in serving hotel and vacation rental guests. Europe accounts for 60 percent of all the vacation rental companies in the world, and the rest of the world accounts for 20 percent.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• SING focused on influencing strategy, direction of high-potential companies
• Company subsidiary partners with one of nation’s largest real-estate brokers
• SinglePoint’s mission is to seize opportunities via aggressive expansion strategy across wide range of assets

SinglePoint Inc. (OTCQB: SING) is a diversified holding company that specializes in the acquisition of small to mid-sized companies. Based in Phoenix, Arizona, SinglePoint’s emphasis is on new technologies and multiple revenue streams. The company provides solar, payment-processing and text-marketing programs. The company offers investment opportunities across a broad array of assets. SinglePoint is accelerating its renewable energy and revenue-growth strategies for residential and commercial solar initiatives primarily by way of its successful Direct Solar of America subsidiary (http://ibn.fm/C3yef).

Recently, SinglePoint CEO Greg Lambrecht discussed company initiatives with MoneyTV’s Donald Baillargeon. Lambrecht talked about SinglePoint’s subsidiary Direct Solar, which has partnered with Phoenix, Arizona-based My Home Group, one of the largest real-estate brokers in the nation. Lambrecht explained that SING was training the group’s agents in solar “so on their business cards, they can put solar certified. But the important thing is, whether their client is buying or selling a house, they can tell them about solar, so in a sense, you know, our company… has hired 2300 reps to help sell our Direct Solar. In fact, last week, they already got three solar deals.”

Lambrecht also noted that estimated numbers for SinglePoint last year look like they are going to come in at approximately $3 million. With the company’s association with My Home Group, Lambrecht projects that this year’s numbers could reach over $10 million. “This solar acquisition, Direct Solar, is really going to show some serious revenues in 2020,” he said.

Regarding the CBD (cannabidiol) and hemp side of SinglePoint’s business, Lambrecht stated that the company has its own 1606 Original Hemp Cigarette brand. The brand is racking up significant sales online, and SING has landed an East Coast distributor with an approximately 8,000 accounts. That distributor is starting to put 1606 Original Hemp Cigarettes in all its stores, Lambrecht reported.

Finally, SinglePoint’s CEO pointed out that investors should recognize says that the company’s stock price is not a clear indication of where the company is. “Solar and renewable energy is, and is going to be, the hottest topic for 2020,” he observed, encouraging investors to take a close look at SING. “In fact, since the start of the year, almost all solar stocks are up, and if you go talk to any broker, they’re putting their clients in solar and renewable energy.” SinglePoint is at the right spot at the right time with solar, he noted.

The company’s Direct Solar subsidiary installs cost-effective, solar-power systems and presently serves multiple states and cities with residential and commercial services. Direct Solar handles everything from paperwork and permits to system requirements and funding.

On the hemp front, SinglePoint’s 1606 Original Hemp line features a filtered, pre-rolled, 100% tobacco- and nicotine-free hemp cigarette. Of note is that the smokable hemp market currently represents about 2% of the overall CBD market – with 250% growth from 2017 to 2018. New Frontier Data estimates that the U.S. legal cannabis market will grow to $30 billion by 2025 (http://ibn.fm/Ere77). Based on those numbers, SinglePoint is at the vanguard of this trend as the company positions itself to supply quality hemp products to a demanding consumer marketplace desiring innovative hemp products.

SinglePoint continues to focus on being a diverse enterprise with an extensive footprint. For investors, the company’s solar and hemp programs offer the potential for major ROI in two thriving industries. SING is delivering on its strategy of acquiring and working with key company management to build successful candidate companies.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• 2020 began with fresh optimism for the hospitality stay industry as U.S. hotels reported a modest rise in revenue and occupancy for the New Year’s holiday period
• Airbnb-style short-term rentals are becoming increasingly prominent in the travel stay market, but the fledgling industry sector continues to struggle with safety and security standards
• Media reports have noted some of the difficulties faced by short-term rental operations, including the case of an actress whose family suffered carbon monoxide poisoning during a holiday stay at a Lake Tahoe property
• Travel accommodations insurer InsuraGuest has developed a model for providing front-line insurance to provide travelers and rental properties peace of mind in dealing with issues that may be exempted from a traveler’s insurance
• InsuraGuest is expanding its licensing and registration to all 50 states and expects to soon expand within Europe and Asia as well

With the rise of Airbnb-type short-term rentals operated by homeowners as profitable, stay-enhancing accommodations for travelers, city administrators and neighbors often find themselves examining the safety and security impact of the fledgling industry.

Actress Anna Faris became an unintended spokeswoman for the industry’s need to standardize guest protections as a first line of defense when she and her family became sick with carbon monoxide poisoning at a Lake Tahoe guest rental home over the Thanksgiving weekend because the home was not equipped with carbon monoxide detectors (http://ibn.fm/ilAnX).

Airbnb advertises a $1 million property damage coverage policy, but a series of lawsuits challenge the company’s reimbursement claims, including a South Carolina coastal island home owner who reported guests seriously damaged the residence (http://ibn.fm/AW0Vw) and a Southwest London developer who reported damages that arose after the service’s customers falsely described themselves (http://ibn.fm/oTzFf).

“Currently, the biggest issue in the vacation rental industry is about standards, and safety and security compliance. Until now, there has been very little guidance for property managers and owners as to how to operate their properties with best practice when it comes to guest safety and security,” Canadian rental certification business founder Wolf Wörster stated in a Viva Glam magazine article on the industry (http://ibn.fm/IM4wG).

Insurtech innovator InsuraGuest Inc. is responding to the concerns from the aspect of insurance needs. InsuraGuest helps the short-term travel stay industry ensure a standard of protection for guests and, in turn, the properties they visit by insuring gaps in medical and site damage coverage. The company’s proprietary software platform is designed to “fill the gap” where other policies’ exemptions may bar reimbursement even though incidents of damage or injury are not regarded as someone’s fault.

InsuraGuest’s policies are responsive to accidental in-room damage, theft of personal property, accidental medical expenses and accidental death and dismemberment for each of the facility’s guests, governed by a single software system. The property becomes an InsuraGuest client, then includes the first-line coverage in the guest rental contract.

InsuraGuest’s proprietary software is expanding its licensing and registration to all 50 states, where it is gaining an increasing number of establishments as clients. The company also expects to advance in European and Asian markets this year (http://ibn.fm/bErYR).

Industry analysts reported that U.S. hotel revenue per available room (RevPAR) rose 4 percent during the New Year’s holiday period and the average daily rate (ADR) and occupancy grew 4 percent and 0.3 percent, respectively, granting hopeful prospects to the hospitality sectors’ outlook for the new year (http://ibn.fm/Lq0zD).

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• For some 15 years, HTC Extraction Systems has built an IP that distills and recycles ethanol and ethanol-based solvents, and is now turning its experience to the cannabinoid extract industries’ potential
• While regulatory federal officials in the United States continue to regard cannabinoid extracts such as cannabidiol (CBD) as potentially unsafe for ingestion, the producers of topicals and oils served by extractors such as HTC Extraction Systems continue to enjoy high-margin possibilities
• The company is installing new equipment at the California-based and Saskatchewan facilities that will give it the capacity to process up to 12,000 pounds of hemp biomass per day at the California site and up to 2 million kg per year for phase 1 at the Canadian site
• HTC’s most recent financial report stated revenues had risen nearly 200 percent on a year-over-year basis, despite the market difficulties many industry players faced during the year

Despite a growing social acceptance, and in many cases even an active embrace, of cannabinoid-derived products for enhancing personal wellness, regulatory liberation in the United States has remained ambivalent and the cannabinoid industry’s biggest players have seen their stocks hammered by a variety of adverse forces throughout North America (http://ibn.fm/AbiTl).

The federal government delivered hope to cannabinoid connoisseurs at the end of 2018 with its passage of the Farm Act that lifted prohibitions against hemp cultivation, but the end of 2019 brought the Food and Drug Administration’s (FDA’s) less-than-encouraging warning that it still does not consider CBD a safe food additive (http://ibn.fm/4DD8P).

While the differing points of view regarding CBD and other cannabinoids even at the administrative levels of state and federal governments foster ongoing debate and legislative wrangling, extraction-service providers such as HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) may expect to remain above the fray as they process hemp biomass to obtain resins, distillates, concentrates and select cannabinoids for high-margin derivatives.

Topicals and oils have largely avoided the attention of the FDA as long as they have avoided making unsubstantiated medical claims in their marketing and packaging. That in turn means companies specializing in the extraction of cannabinoids for such products can prove to be a refuge for investors looking for a cannabinoid-related industry to take off (http://ibn.fm/fO9wI), regardless of the FDA’s eventual decision.

HTC Extraction Systems has built its proprietary purification technologies on the 15 years of advances it has made in distillation processes that remove ethanol and ethanol-based solvents used in the extraction process. The company’s trademarked Delta Reclaiming System technologies for CBD, solvents and glycols recycle and reuse the extraction ethanol used in the CBD extraction process, limiting CBD waste through the re-extraction of all wastes collected from the purified ethanol, according to the company.

HTC Extraction Systems’ working relationships with other cannabinoid industry players further shore up its revenues possibilities. Most recently, the Canadian company recently closed its acquisition of a California-based company in the United States. The recently acquired, Kase Farma Inc., is authorized to work with hemp cultivation, extraction, refining, formulation and business operations in the world’s largest cannabinoid market (http://ibn.fm/KBooK), and HTC Extraction will reap the experience of Kase Farma’s former owner, Starling Brands, Inc., which remains involved through a management services agreement for navigating the business and regulatory climates in California.

New equipment that will enable Kase Farma to process and distill up to 12,000 pounds a day of dried hemp biomass that, at an 8 percent CBD yield, will give over 400,000 grams daily of CBD and a sizable profile during the upcoming cultivation season. New equipment HTC Extraction Systems is installing at its Saskatchewan facilities will similarly allow the company to receive a projected 2 million kg of hemp biomass for extracting CBD Full-Spectrum Oil (FSO) distillate north of the border under a tolling strategy coordinated with highly recognized area farmers.

While year-end financial reports are pending, the company’s third-quarter statement reported revenues had grown by nearly 200 percent year-over-year, further demonstrating HTC Extraction Systems’ potential for financial strength (http://ibn.fm/VmA5S).

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• CIIX leverages its robust financial expertise to become leader in nascent Chinese CBD market
• CEO discusses potential health benefits of CBD-based products as China – and world – faces spread of coronavirus
• Wang emphasizes tremendous opportunities offered by CBD Biotech’s products in enormous yet untapped CBD Chinese market

California-based ChineseInvestors.com Inc. (OTCQB: CIIX) is a financial-news media and content platform founded in 1999 that has become a leading financial information platform for Chinese-speaking investors in the United States and China. Recognizing exceptional opportunities in the emerging cannabis industry, CIIX is leveraging its tremendous financial expertise to establish itself as a leader in China’s developing cannabidiol (CBD) industry.

Although cannabis is currently illegal in China, hemp-based CBD can be legally added to nutrition and health products and cosmetics, opening up massive opportunities in the untapped Chinese CBD market. CIIX has created a three-year development plan to pioneer an attractive lineup of CBD-based products through its subsidiary, CBD Biotech, and capitalize on the tremendous potential of the enormous Chinese market, where the benefits of CBD oil have not been widely recognized yet.

In addition, in a bid to meet growing consumer expectations for seamless digital customer experiences, the company is developing a CBD-focused platform for Chinese people to review and discuss various CBD products. The platform is intended to be a Yelp-style mobile app and will be the first CBD social-media mobile app that caters to Chinese-speaking customers worldwide. The company has already launched another digital product, www.ChineseCBDoil.com, the world’s first online, CBD-infused, health-products store in Chinese.

A growing number of Chinese people are becoming aware of the numerous health benefits of CBD oil for the treatment of a number of conditions such as stress, anxiety, poor sleep, Alzheimer’s disease and more. In a recent interview with MoneyTV’s Donald Baillargeon, CIIX CEO Warren Wang discussed health benefits of CBD-based products offered by CIIX, emphasizing those that are relevant in the current environment where the coronavirus is an international concern.

Speaking to MoneyTV’s vast audience, which numbers over 200 million households in more than 75 countries, Wang said that the need for health-related products to potentially address the virus that originated in the Chinese province of Wuhan presents a tremendous opportunity for CBD Biotech. The innovative lineup of the company’s CBD health and cosmetics products may be particularly helpful when the world, and China in particular, are under the threat of the virus. Among others, Wang mentioned the company’s hemp-infused soap and also noted CBD Biotech is planning to roll out the first hemp-infused protective face mask.

“I’m not a doctor; I cannot say that CBD can help your immune system, but I speak from my three-year experience,” Wang stated in the interview (http://ibn.fm/CZWAT), indicating that seeking medical help is essential while CBD products can be a preventative measure. “I am the first one in the public market field inside China selling CBD. In the long run, we have tremendous opportunities. You can call me the number-one CBD salesman in China.”

The CIIX business model is based on the sound business strategy of diversifying income streams between attractive business lines that, although separate, are centered around Chinese investors or consumers, making the company an attractive investment opportunity. Particularly compelling as the company has announced a Nasdaq IPO planned for the beginning of 2020, CIIX can bring investors benefits of early entrance in the company with a sound, diversified business model and enormous target market that offers significant opportunities.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• NGTF partners with leading marketing company to install coupon machines in more than 700 supermarkets
• Company expects initiative to drive massive consumer trial in their ‘natural habitat’ – at home, in front of TV
• Nightfood adds seasoned sales director to oversee 2020 supermarket expansion

Nightfood Holdings Inc. (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion nighttime snacking problem, is partnering with News America Marketing to kick off its first-ever in-store promotional activities (http://ibn.fm/p9I8q). The in-store initiative includes installing coupon machines in approximately 700 of Nightfood’s high-volume supermarket partners.

“These coupon machines are extremely cost effective, and we’re expecting this campaign to be very impactful,” Nightfood CEO Sean Folkson stated in a news release, further noting that participating chains include existing Nightfood partners, along with new major chains in which Nightfood has secured distribution. “In the crowded ice cream section, where product is literally merchandised behind closed doors, being able to break out from behind the door and into the vision of the consumer can play an important role in driving trial and winning new customers.”

The machines are designed to encourage consumers to purchase Nightfood products and then have their first Nightfood ice-cream experience at home, in what Folkson calls “their natural habitat.”

“Anytime a consumer can enjoy their first pint of Nightfood at home, in front of the TV or whenever the cravings normally hit, that’s a win for us,” Folkson continued. “We’re looking for this campaign to drive that kind of trial in a much more cost-effective way than in-store product demonstrations, which might last a few hours and give consumers just a small taste. These displays are there for several weeks, working hard 24 hours a day, and impossible to miss for anybody in the ice cream section.”

Nightfood’s partner in this strategic initiative, News America Marketing, provides comprehensive in-store marketing media options in more than 60,000 stores across the United States and Canada. News America clients include some of the most established consumer brands in the world along with fast-growing category pioneering brands. “We’re excited to be supporting and working with Nightfood as they expand distribution into additional supermarket chains around the country,” said Gabrielle McMahon of News America Marketing. “We’ll work together in the coming months to apply best practices and identify the optimal mix of tactics to drive success at retail for this unique and innovative brand.”

The announcement of the in-store promotional campaign came on the heels of Nightfood adding a seasoned sales director to its team (http://ibn.fm/1Mh8R). The company partnered with WeStock’s new shared sales-director program, dubbed Radish, to add Jessie Trinchard to the Nightfood roster. Radish provides growing brands with a shared, industry-leading sales director to oversee and coordinate national sales in a quick and affordable way. Trinchard will help Nightfood further expand the brand’s distribution footprint and work closely with the growing number of supermarket chains carrying Nightfood ice cream to help drive maximum awareness and sales.

Trinchard is an industry veteran with more than a decade of experience in sales and marketing-management positions in high-growth brands in the food and beverage sector. Her résumé includes management and director experience in multiple national brands that have since been acquired for an aggregate of over $500 million.

By helping consumers solve their night snacking in a better, healthier, and more sleep-friendly way, Nightfood is establishing the leading position in the nighttime-snacking category where American consumers are generally dissatisfied yet still spend more than $50 billion annually. Nightfood – winner of the 2019 Product of the Year Award in the ice cream category (http://ibn.fm/r5hJN) – is the creator of delicious and better-for-you ice cream formulated by sleep and nutrition experts.

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF